Marissa Fayer

Transforming Healthcare System: How Supply Chain Innovation Drives Health Equity and Bridges Disparities — Bright Chimezie Irem In the ongoing effort to bridge health disparities, reduce health gaps/inequities while increasing health equity, optimizing health and pharmaceutical supply chains emerges as a crucial strategy. Bright Chimezie Irem looked into how these supply chains, integral to healthcare delivery, can be effectively managed to enhance health equity, particularly in the last-mile population & hard-to-reach regions. In my work on - https://lnkd.in/dT-2A748 - I began by examining the challenges in health and pharmaceutical supply chains and their direct impact on #healthequity . Inefficiencies in these systems often lead to medicine shortages and inaccessible healthcare, disproportionately affecting marginalized communities. Highlighting the role of government and policy-making, I explored how governmental interventions, through policy frameworks and regulations, can streamline supply chain processes and foster public-private partnerships. These collaborations are critically essential in leveraging private sector efficiency for public health benefits. A focal point of my presentation is the innovative model of AfriPharm Medicals Group, which exemplifies how private sector strategies can address public healthcare challenges. AfriPharm's approach in tackling supply chain inefficiencies showcases a scalable and sustainable model, emphasizing the importance of collaboration in enhancing health equity for better health outcomes. Furthermore, I discussed the strategies for successful last-mile delivery, ensuring that essential healthcare services and products reach the most remote areas. This is vital for achieving true health equity. Measuring the success and impact of these initiatives is crucial. I looked into various #metrics and methods used to evaluate #supplychain optimizations, highlighting their significance in continuous improvement efforts. Looking ahead, I discussed future directions and innovations in #supplychainmanagement, emphasizing the role of emerging technologies and digital transformation. Optimizing health and pharmaceutical supply chains is a collaborative journey. By integrating innovative strategies, governmental support, and private sector efficiencies, we can significantly advance towards equitable healthcare access for all. #Read my full article on: https://lnkd.in/dT-2A748 Atlantic Fellows for Health Equity #ExchangeAlumni - Alumni Affairs - State Dept.#ExchangeAlumni U.S. Department of State | Bureau of Global Health Security and Diplomacy Mandela Washington Fellowship YALI Network #HealthEquity #SupplyChainOptimization #PublicHealth #Pharmaceuticals #HealthcareInnovation #DigitalTransformation #GlobalHealth #HealthPolicy #SustainableHealthcare #LastMileDelivery

2

2 Comments

Investing in companies that fill needs for health systems is a growth opportunity for both delivery organizations and start ups. Some systems are jumping in on their own, while others are partnering with like minded systems or with established VC firms. While this is a relatively new trend for systems, health plans have been making similar bets for many years. The benefits of becoming a health system portfolio company can be significant. Data, access to beta populations and real world coaching can be extremely beneficial. Start ups get mentoring and systems have to ability to leverage outside resources to solve relevant business problems. I predict a booming business!

4

Here's what's happening in the Kidneyverse - your monthly dose of kidney innovation news, funding, policy, and reasons for optimism.💫👇🏼 Full update goes out next week: 📰 https://lnkd.in/egGsNwqs -- TOPICS: 🟪 Discovery & Innovation 🟦 Market Insight 🟨 Policy & Regulation 🟥 Community Voices -- STORIES: 🟪 The team at 34 Lives just rescued their first human kidney that had been deemed not usable for transplant! The company is on a mission to decrease the number of kidneys in the US that are recovered with the intent to transplant but subsequently not used. (h/t Kevin Longino) 🟪 Toku Eyes just received FDA Breakthrough Device designation for its MyKidneyAI product that uses #AI to analyze retinal images from routine eye exams to detect CKD risk in people with diabetes. (h/t Ehsan Vaghefi) 🟦 Outset Medical, Inc. announced it has received FDA 510(k) clearance of TabloCart™ with prefiltration! (h/t Fierce Healthcare) 🟨 CMS announced the proposed Increasing Organ Transplant Access Model earlier this week. The mandatory model is designed to support better outcomes for people living with kidney disease by incentivizing an increased number of kidney transplants. (h/t SMIT PATEL💊📲) 🟨 A newly introduced bill would provide funding for staff assistance and more training options for home dialysis. The legislation proposes covering the cost of in-home health care support staff for up to 90 days with an add-on payment to the dialysis payment bundle. (h/t Kerstin Leuther, PhD) 🟨 The Apple Watch AFib feature just became the first #digitalhealth product to receive FDA approval under the MDDT program. It will be used as a tool to assess atrial fibrillation burden estimates within clinical studies. (h/t Jaydeo Kinikar) 🟥 On May 6, 2024, the Kidney Health Initiative convened a 50+ person vascular access workshop to identify opportunities and challenges for much-needed innovations with POVs shared b/n care partners, patients, and clinical care teams with entrepreneurs, companies, investors, NIDDK, and FDA. (h/t Mark David Lim, Ph.D. PMP) 🟥 For those following the latest VBC and CKCC news, a comment thread on Nishant Jalandhara's latest post is an insightful collection of diverse POVs on what's happening in the space. It includes both high-level guiding wisdom and in-the-weeds candor on what it takes to participate in these models. (Much) more to come on this front via Signals From [Space]. 🟥 An article in MedCity News talks about the polarizing rhetoric around digital health these days. Authors Alyssa Jaffee and Mona Siddiqui, MD, MPH, MSE share thoughts on the early innings for #healthtech with examples like NOCD, Jasper Health, GroundGame.Health, Waymark, and Author Health. *** Each month I send out a recap of dozens of headlines like these, a few closer looks, and visuals of the month. Which resonated with you? Let us know in the comments below (and say hi next week at NKF👋🏼). 👉🏼 https://lnkd.in/egGsNwqs

34

7 Comments

Next week I will be a speaker at the Aspen Institute’s @AspenDigital's inaugural Product Equity Summit. 👇🏾 Here are my talking points for discussion with the summit attendees: 🎤 Community (patient) engagement and intersectionality when designing products and solutions  🎤 The role data plays in addressing disparities in health and what lessons we can learn as it relates to data collection; referencing women’s health data gaps and diagnosis challenges as examples 🎤 Emerging trends or technologies I foresee shaping the future of health equity and the healthcare industry more broadly (federated machine learning, synthetic data, patient opt-in data generation/collection methods) What did I miss? Are there points you think I should discuss? Let me know in the comments below👇🏾 or send me a message 📩 . I'm looking forward to learning from and getting to know other innovators dedicated to health equity. If you are in DC, consider attending the summit. The three-day event unites product equity leaders within tech and key civil society stakeholders in a collective effort to advance industry standards and collaboration in product equity. #TechAccountabilityCoalition #WomensHealth #Healthequity #ResponsibleAI #TechForAll #ProductInclusion #ProductEquity

69

8 Comments

💛 this! The Wonder Woman Collective is a stellar example of how collaboration should revolutionize an industry—specifically women’s healthcare. This powerhouse alliance, formed by five innovative companies—Paloma Health, Neura Health, LEVY Health, Seven Starling, and Origin—is making waves by targeting the significant and often overlooked gaps in women's health. Their approach is multifaceted and strategic, focusing on improving healthcare outcomes, advancing health equity, reducing healthcare costs, and boosting productivity for women. What’s super cool about this collective is how they exemplify the four key principles needed for impactful change: 1.  Working in Tandem: These companies aren’t just sharing goals; they're integrating their expertise to provide comprehensive care, which includes clinical decision support and integrating electronic health records. Their joint efforts are a testament to the power of partnership in driving forward healthcare innovation. 2.  Mutual Accountability: By collaborating, these companies hold each other accountable to prioritize evidence-based, compliance focused, women-centric healthcare solutions, ensuring that they keep the focus on what truly benefits women’s health. 3.  Speed and Efficiency: They understand that in healthcare, time is often of the essence. Through their collaboration, they've accelerated the process of innovation and implementation of healthcare solutions, avoiding the redundancy of working in silos. 4.  Elevating Women’s Health as Healthcare. Period: This collective boldly declares that women's health issues deserve the spotlight and are integral to the broader healthcare narrative. Their actions and outcomes are making it clear that women's health is essential healthcare. It’s not just about better health outcomes—it’s about setting a new standard where women's health is given the priority, innovation, and respect it deserves. Let’s hear it for The Wonder Woman Collective. Rock on, ladies! Femtech Insider https://lnkd.in/eJBr7dB2 #womenshealth #femtech #collaboration

27

Healthcare in the U.S. is in crisis but value-based care estimated to add $1 Trillion in value. You nailed it. Irem Rami, Sam Lesser, Suraj Shah, Unmesh Srivastava #healthcare #medicare #healthequity

14

Age and Health Equity: A Generational View Diving into how age impacts health equity! Our latest infographic uncovers key insights across generations—from children to seniors. Here’s what we found: 1. Age Groups: Breaking down health equity issues by children, adults, and seniors. 2. Access to Healthcare: Analyzing how different generations face unique barriers to accessing care. 3. Health Outcomes: Comparing health outcomes across ages to spotlight disparities and needs. Swipe to explore our findings and see how age influences health equity. Let’s spark a conversation on how we can improve health access and outcomes for every generation. Join the movement to advocate for equitable healthcare solutions that serve all ages. #HealthEquity #GenerationalHealth #InclusiveHealthcare

10

1 Comment

There are good takeaways from this conversation and more to come. - Leaders must fully grasp the intricacies of risk adjustment, including its interconnections with other departments and the optimal staffing model. Stay tuned for more insights!

3

Every year at CES we see a lot of promising health tech prototypes and concepts - from noninvasive CGM’s to patches for everything - very few actually make it to market. Often, when it does, the launch product falls short from the initial promise. The reason: FDA Approval. The FDA is designed to protect public health - regulating medical devices falls under its prevue. The FDA clearance process is rigorous and complex to navigate. It a process that takes years - not months - something that the tech industry isn’t used to. A device would need to show clinical-level accuracy for measurements - with a margin of error of under 4 percent or better. Data infrastructure would need to be HIPPA compliant. FDA also requires areas such as communication protocols, cloud infrastructure, and cybersecurity to be include as a part of the filing. The workaround: Wellness Devices. Most consumer health devices focus on wellness features because they lack FDA certification. As a result, they can only display the data but lack any true medical or diagnostic application. As consumers are pushing their wearables to be health devices, it is getting more and more difficult for wearable companies to hide behind the “wellness” label as an increasing number of companies achieve FDA clearance. Which is a big reason why we wanted to invest in bringing FDA approval capabilities in-house to serve our portfolio of brands. In partnership with B-Secur, SweatWorks can now help any wearable product (and associated software functions) achieve expedited FDA certification. This is a first for a digital agency and has already led to several news devices starting on the FDA approval journey. How important do you view FDA certification for the next generation of wearables devices? Let me know below. 👇 #wearables #fda #certification #innovation #technology #data #fitness #wellness #hardware #medical #devices #CES

49

6 Comments

Happy FTC voting on banning non-competes day for those who celebrate. 🎉🥳 ——— Hi, I'm Dr. Mario Amaro, Founder and CEO Ease and I talk about all things starting, running, and growing a private practice with AI. Follow me, if you are planning to start one or are currently figuring out creative ways to grow one. #PrivatePractice #SelfEmployment #HealthcareOnLinkedin #HeyEase #IndependentTogether

23

8 Comments

Did you know there is a Women's Health Gap? I had the opportunity to moderate a panel recently that discussed FemTech. For those unfamiliar with FemTech, which is short for "female technology," it encompasses diagnostics, hardware, software, and products and services that leverage technology to prioritize women's health. FemTech products include menopause management solutions, fertility tracking apps, maternal care products, sexual health solutions, wearables that track biometric data, and more. The revenue market for FemTech varies depending on who reports the numbers. Still, most indicate the market is currently in the range of $50 billion globally and is expected to grow over the next ten years to $100 billion worldwide. Part of our conversation during the panel discussion focused on the funding landscape for women's health technology. Although I was aware of the chronic underfunding of women's health in general, the panel discussion illuminated the realities behind the statistics, including some discussion about the lack of gender-specific data. The panel noted that access to this data would provide a more complete picture of the disease burden on women, which could be used to support the case for more women-focused research. A recent report, 𝐶𝑙𝑜𝑠𝑖𝑛𝑔 𝑡ℎ𝑒 𝑊𝑜𝑚𝑒𝑛'𝑠 𝐻𝑒𝑎𝑙𝑡ℎ 𝐺𝑎𝑝: 𝐴 $1 𝑇𝑟𝑖𝑙𝑙𝑖𝑜𝑛 𝑂𝑝𝑝𝑜𝑟𝑡𝑢𝑛𝑖𝑡𝑦 𝑡𝑜 𝐼𝑚𝑝𝑟𝑜𝑣𝑒 𝐿𝑖𝑣𝑒𝑠 𝑎𝑛𝑑 𝐸𝑐𝑜𝑛𝑜𝑚𝑖𝑒𝑠, by the World Economic Forum in collaboration with the McKinsey Health Institute, highlights the stark reality: "…narrowing the women's health gap would allow 3.9 billion women to live healthier, higher-quality lives. It could also allow at least $1 trillion to be pumped into economic productivity annually." Despite women making up half the population, women's health continues to remain significantly underfunded and understudied in scientific research. Public funding, essential for health science advancements, allocates only a small fraction to women's health-specific research. For instance, as reported in the above report, the National Institutes of Health (NIH), the world's largest public funder of biomedical research, dedicates just 11% of its budget to women's health. Additionally, the report goes on to note that only 4.5% of the NIH's budget for coronary artery disease research focuses on studies centered on women, even though the year following a heart attack, women experience a 50% higher mortality rate versus men. This disparity is an example of the urgent need for more targeted research and funding to address the unique health challenges faced by women. Now is the time for stakeholders across the healthcare, technology, and investment sectors to recognize and prioritize the funding and support for women's health initiatives, including FemTech. Let's drive innovation, support groundbreaking research, and invest in the future of women's health to ensure a healthier world for all.

21

6 Comments

🌟 Reminder: Impruvon Health Webinar Today at Noon! 🌟 Good morning, #GMAFamily! Just a quick reminder that our highly anticipated webinar on Impruvon Health's innovative healthcare solutions is happening TODAY at 12 PM CST. Don't miss out on this opportunity to learn how their tailored solutions are making a significant impact in IDD Residential and Senior Communities. What to Expect: - Insightful Presentations: Discover the latest advancements in medication management and how they can streamline care processes in your facility. - Live Demonstrations: See Impruvon Health's technology in action and understand the practical applications that can transform your approach to care. - Expert Q&A: Have your questions answered by the experts. This is your chance to dive deeper into the specifics and benefits of integrating Impruvon Health solutions. Why Join? Whether you’re a healthcare professional looking to enhance your facility's operations or you're interested in the ways technology can improve care delivery, this webinar is for you. Gain valuable insights and practical knowledge that can be applied directly to your daily operations. Last Chance to Register: If you haven't signed up yet, it's not too late! Join us to explore how we can help you improve care, reduce errors, and ensure a higher quality of life for residents. Send an email to info@graymattersalliance.com with 'Webinar Invite' in the subject line. Let's make the most of this learning opportunity. See you at noon! #ImpruvonHealth #HealthcareInnovation #GMAWebinar #MedicationManagement #CareSolutions #AssistiveTechnology

1

Blue Health Intelligence, a data analytics and software company, undertook an evaluation of almost 170,000 unique GLP-1 users for weight loss, notes less than half of those prescribed stay on the medication for 12 weeks or more. Younger adults were less likely to continue the drug, whereas those who were prescribed the medication by an endocrinologist or obesity medicine specialist were more likely to continue for longer. Indeed, this data states 30% of patients dropped out of treatment after the first four weeks, and 58% at 12 weeks. Those who dropped out are unlikely to achieve clinically meaningful weight loss.  The likelihood of continuance was further exacerbated for those with health inequities or who lived in underserved health regions. The data comes from Blue Cross Blue Shield Association members participating in Plans that provided coverage of these products, from 2014 through to end of 2023. Razia Hashmi, vice president for clinical affairs at Blue Cross Blue Shield wants to ‘…paint a clearer picture of what makes somebody successful.’ The missing piece here is why the patients stopped – side effects, failure to achieve initial weight loss, stigma and discrimination, or coverage issues related to cost and access. My longtime friend, colleague and bariatric surgeon at Stanford University, Dr. Dan Azagury rightly states ‘…The goal is for patients to stay on this for a significant amount of time. Most likely… beyond 12 weeks.’ https://lnkd.in/ediQskQx

19

5 Comments

There is such a need for new innovation in digital health. Whether it is Remote Patient Monitoring to support the new patient at home models, or better ways to streamline provider workflow or leveraging AI for better RCM- digital health investment is so necessary.

7

We just released our H1 2024 New York Healthcare Innovation Report, and it's generating lots of buzz. Why? Funding is up: 56 companies raised $2.2B in H12024, about 35% greater than the same period last year. There's lots of positive momentum within the NY #digitalhealth community heading into the second half of the year. Download the Digital Health New York report : https://go.dhny.co/h1-2024

77

2 Comments

At Oral Genome, our commitment extends beyond oral health to encompass comprehensive health equity. Our approach recognizes the critical link between oral health and overall systemic health, a connection often overlooked in traditional healthcare models. Recent insights highlight the vast disparities in oral healthcare, with significant gaps in access and outcomes among different communities. These disparities are not just about health—they represent a broader issue of social justice. Oral Genome is at the forefront of addressing these inequities by integrating advanced dental diagnostics with proactive health management. Our technologies and services are designed to provide equitable access to premium oral healthcare, regardless of a patient’s background or geographic location. By prioritizing preventative care and education, we aim to improve health outcomes across the board, ensuring that everyone has the opportunity to achieve optimal health without financial or social barriers. The healthcare landscape is changing, and really pleased to see the article JAMA Network Health Systems & Recruitment put out to really shed light into how harnessing artificial intelligence can address oral health disparities. #HealthEquity #OralHealth #SocialJustice #InnovationInHealthcare #dentalhealth #oralgenome #oralhealthandwellness #salivatesting https://lnkd.in/ech2x6kv Norman Kwong, MBA

32